It has been reported that soluble TNFR2, which is highly secreted by Tregs in the tumor microenvironment, can bind to membrane TNF on tumor cells to form a reverse transduction signaling pathway to induce the NF-κB pathway, thereby promoting the survival of lymphoma cells (14). Here, TNFRSF1B is linked to neoplasm.